India accuses Myntra of breaching foreign investment rules
The case comes amid growing scrutiny of e-commerce players in India. An antitrust investigation last year found Amazon and Walmart's other e-commerce platform, Flipkart, favoured select sellers and resorted to "predatory pricing", hurting smaller retailers. The companies denied the allegations. Recommended For You
The details of the case also emerged just as India and the United States are struggling to strike a trade deal.
The restrictions that Amazon and Walmart face in the South Asian country have been a part of the negotiations, and have for years been a sore point between New Delhi and Washington.
Myntra, owned by Flipkart, sells fashion brands on its own e-commerce website.
Detailing its findings from an investigation, India's Enforcement Directorate said that Myntra declared it was a wholesaler and received $192 million of foreign investment, but then sold most of its goods to a group entity that retailed those products to consumers.
"Myntra Designs Pvt. Ltd was actually carrying out multi-brand retail trading in the guise of wholesale cash carry," the agency said.
Myntra said in a statement that it had not received documents related to the case from the authorities but that it remained "fully committed to cooperating with them at any point of time".
The firm is "committed to upholding all applicable laws," Myntra added.
Walmart did not immediately respond to a request for comment.
In a bid to protect domestic retailers and traders, India prohibits foreign companies engaging in wholesale business to make any direct sales to consumers.
E-commerce business is also restricted, with foreign-owned companies like Myntra, Amazon and Flipkart allowed to operate marketplaces to connect buyers and individual sellers online, but not to stock goods or offer them directly to consumers.
The Enforcement Directorate said it had filed a complaint against Myntra before an adjudicating authority, without giving details.
Flipkart and Amazon have also faced allegations of breaching India's foreign investment rules.
A 2021 Reuters investigation based on internal Amazon documents showed the company for years gave preferential treatment to small groups of sellers, and used them to bypass Indian laws. Amazon has denied wrongdoing.
Amazon and Flipkart are leading players in India's e-commerce market, which was estimated to be worth $125 billion in 2024 and is set to top $345 billion by 2030, according to India Brand Equity Foundation.
Founded in 2007, Bengaluru-based Myntra was acquired by Flipkart in 2014. Walmart bought a controlling stake in Flipkart in 2018 for $16 billion.
Myntra reported revenues of nearly $600 million in 2023-24, up 15 per cent on the previous year.
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Zawya
11 hours ago
- Zawya
ADNOC's Covestro buy may be boosted by foreign subsidies, EU warns
Abu Dhabi state oil giant ADNOC's 14.7 billion euro ($17.2 billion) bid for German chemicals company Covestro may face hurdles after EU antitrust regulators opened an investigation on Monday into potential distortions caused by foreign subsidies. ADNOC struck the deal to buy Covestro last October, marking its biggest ever acquisition and one of the largest foreign takeovers of an EU company by a Gulf state. The European Commission, which has been reviewing the deal under its foreign subsidies rules since May, opened an in-depth investigation on Monday, warning that subsidies granted by the United Arab Emirates could distort the EU internal market. The Commission, which acts as the EU competition enforcer, said the possible foreign subsidies include an unlimited guarantee from the UAE, as well as a committed capital increase by ADNOC into Covestro. "ADNOC may have offered an unusually high price and other favourable conditions, which may have deterred other investors from making an offer," it said in a statement. The EU investigation will also look into possible negative effects in the internal market resulting from the merged company's activities once the deal is concluded. "XRG and Covestro remain in constructive discussions with the European Commission and are cooperating to conclude the FSR review," the German company said in a statement. XRG is the international investment arm of ADNOC. The Commission set a December 2 deadline for its decision on the deal. The EU's Foreign Subsidies Regulation (FSR) focuses on unfair foreign aid for companies in a bid to rein in unfair competition from non-EU companies subsidised by their governments. UAE telecoms group e& secured EU approval to buy parts of Czech telecoms company PPF last year after agreeing to scrap an unlimited state guarantee and not to channel foreign subsidies to the activities of the merged company in the EU. ($1 = 0.8569 euros) (Reporting by Bart Meijer. Additional reporting by Patricia Weiss in Frankfurt and Bartosz Dabrowski in Gdansk. Writing by Foo Yun Chee. Editing by Louise Heavens and Mark Potter)
Khaleej Times
12 hours ago
- Khaleej Times
State of play in Trump's tariffs, threats and delays
Dozens of economies including India, Canada and Mexico face threats of higher tariffs Friday if they fail to strike deals with Washington. Here is a summary of duties President Donald Trump has introduced in his second term as he pressures allies and competitors alike to reshape US trade relationships. Global tariffs US "reciprocal" tariffs -- imposed under legally contentious emergency powers -- are due to jump from 10 percent to various steeper levels for a list of dozens of economies come August 1, including South Korea, India and Taiwan. The hikes were to take effect July 9 but Trump postponed them days before imposition, marking a second delay since their shock unveiling in April. A 10 per cent "baseline" levy on most partners, which Trump imposed in April, remains in place. He has also issued letters dictating tariff rates above 10 percent for individual countries, including Brazil, which has a trade deficit with the United States and was not on the initial list of higher "reciprocal" rates. Several economies -- the European Union, Britain, Vietnam, Japan, Indonesia and the Philippines -- have struck initial tariff deals with Washington, while China managed to temporarily lower tit-for-tat duties. Certain products like pharmaceuticals, semiconductors and lumber are excluded from Trump's "reciprocal" tariffs, but may face separate action under different authorities. This has been the case for steel, aluminum, and soon copper. Gold and silver, alongside energy commodities, are also exempted. Excluded too are Mexico and Canada, hit with a different set of tariffs, and countries like Russia and North Korea as they already face sanctions. Canada, Mexico Canadian and Mexican products were hit by 25 percent US tariffs shortly after Trump returned to office, with a lower rate for Canadian energy. Trump targeted both neighbors over illegal immigration and fentanyl trafficking, also invoking emergency powers. But trade negotiations have been bumpy. This month, Trump said Canadian goods will face a higher 35 percent duty from August 1, and Mexican goods will see a 30 percent level. Products entering the United States under the USMCA North American free trade pact, covering large swaths of goods, are expected to remain exempt -- with Canadian energy resources and potash, used as fertilizer, to still face lower rates. China focus Trump has also taken special aim at China. The world's two biggest economies engaged in an escalating tariffs war this year before their temporary pullback. The countries imposed triple-digit duties on each other at one point, a level described as a trade embargo. After high level talks, Washington lowered its levies on Chinese goods to 30 percent and Beijing slashed its own to 10 percent. This pause is set to expire August 12, and officials will meet for further talks on Monday and Tuesday in the Swedish capital Stockholm. The US level is higher as it includes a 20 percent tariff over China's alleged role in the global fentanyl trade. Beyond expansive tariffs on Chinese products, Trump ordered the closure of a duty-free exemption for low-value parcels from the country. This adds to the cost of importing items like clothing and small electronics. Autos, metals Trump has targeted individual business sectors too, under more conventional national security grounds, imposing a 25 percent levy on steel and aluminum imports which he later doubled to 50 percent. The president has unveiled plans for a 50 percent tariff on copper imports starting August 1 as well and rolled out a 25 percent tariff on imported autos, although those entering under the USMCA can qualify for a lower rate. Trump's auto tariffs impact vehicle parts too, but new rules ensure automakers paying vehicle tariffs will not also be charged for certain other duties. He has ongoing investigations into imports of lumber, semiconductors, pharmaceuticals and critical minerals that could trigger further duties. Legal challenges Several legal challenges have been filed against the tariffs Trump invoked citing emergencies. The US Court of International Trade ruled in May that the president had overstepped his authority, but a federal appeals court has allowed the duties to remain while it considers the case. If these tariffs are ultimately ruled illegal, companies could possibly seek reimbursements.
Zawya
13 hours ago
- Zawya
Dr. Moopen's Legacy Scholarship & Fellowships launched to aid 25 students from across India
First Private Medical College in Kerala to Offer 100% Tuition Fee Waiver for Eligible MBBS Students 100% tuition fee waiver for 25 students comprising of 5 MBBS aspirants, 10 BSc Nursing and 10 students The annual scholarship would be granted to students seeking to join Dr. Moopen's Medical College, Nursing College and College of Pharmacy in Wayanad, Kerala. 125 students are expected to benefit from the initiative over the next 5 years, with Dr. Moopen's Education and Research Foundation committing INR 3 crore per year towards this. Kochi – In a path breaking initiative to make medical education accessible to meritorious students and students from economically challenged backgrounds, Padma Shri Dr. Azad Moopen, Founder & Chairman of Aster DM Healthcare and a globally recognized philanthropist, has announced an annual scholarship programme Dr. Moopen's Legacy Scholarship & Fellowships Programme aimed at supporting meritorious students seeking admissions in Dr. Moopen's Medical College, Dr Moopen's Nursing College and Dr Moopen's College of Pharmacy in Wayanad, Kerala. This initiative marks the first time a private medical college in Kerala is offering a 100% tuition fee waiver for eligible meritorious medical students, promising to transform access to quality healthcare education for talented, deserving individuals. The scholarships will be offered to 25 eligible students applying to MBBS, BSc Nursing, and BPharm courses. Each year, 5 MBBS, 10 BSc Nursing, and 10 BPharm students will receive these scholarships. For MBBS scholarships, selection will be based solely on merit, recognizing and encouraging students with excellent academic track records and top NEET rankings. While these students often receive priority in admissions, this initiative aims to provide further recognition. Meanwhile, BSc Nursing and candidates will be chosen based on academic merit and financial need. The scholarship will cover the entire tuition fees, subject to the students meeting basic academic performance and adherence to program guidelines. Over the next five years, 125 students will benefit, with the total financial commitment expected to exceed INR 3 crore per annum. Dr. Azad Moopen, Founder & Chairman, Aster DM Healthcare and Managing Trustee of Dr. Moopen's Education and Research Foundation said, 'Education is the foundation of a stronger and more inclusive society. I have heard countless stories of talented students who were forced to abandon their dreams of becoming doctors, nurses, or pharmacists simply because they lacked financial support. I firmly believe that no capable student should have to give up such aspirations due to economic constraints especially in a field as vital as healthcare. The Dr. Moopen's Legacy Scholarship & Fellowships Programme marks a formal and larger commitment: not just to fund education, but to create opportunities that can transform the lives of individuals, their families, and an entire community. By empowering meritorious students and students from economically challenged backgrounds, we aim to nurture a new generation of healthcare professionals who will carry forward the mission of delivering compassionate, quality care to those who need it most.' This initiative builds on Dr. Moopen's vision of transforming healthcare in underserved regions. Dr. Moopen's Medical College, established in 2012, was the first medical college in Kerala to be set up in a hilly, tribal, and backward district. Its mission has been to address the shortage of quality healthcare in such regions while inspiring local communities including tribal youth to pursue careers in medicine. The Dr. Moopen's Legacy Scholarship & Fellowships Programme extends that mission, ensuring financial constraints never stand in the way of deserving talent. Having nurtured around 900 young doctors across 6 batches, Dr. Moopen's Medical College is a sustainable medical education hub in the country. The college has quickly become a center of excellence, boasting experienced faculty, a high-quality library, a museum, and a hospital operating with tertiary care facilities. Applications for the scholarship will open on 28th July 2025 and applicants can find more details and eligibility guidelines on – Dr. Azad Moopen, Founder & Chairman, Aster DM Healthcare and Managing Trustee, Dr. Moopen's Education and Research Foundation (DMERF), Ms. Alisha Moopen, Deputy Managing Director, Aster DM Healthcare India and Trustee, DMERF, Mr. Anoop Moopen - Director, Aster DM Healthcare and Trustee, DMERF, Mr. T.J Wilson, Executive Director & Group Head-Governance & Corporate Affairs and Dr. Shanavas Palliyal, DGM Operations, Dr. Moopen's Medical College spoke during the launch conference held at Kochi. About Aster DM Healthcare, India Aster DM Healthcare Limited is among India's leading healthcare providers, operating 19 hospitals with 5,159 beds, 10 clinics, 203 pharmacies (under Alfaone Retail Pharmacies Private Limited), and 262 laboratories and experience centers across five states. Our mission is simple: 'We'll Treat You Well.' We leverage innovative digital standards and cutting-edge technology to deliver quality healthcare across primary, secondary, tertiary, and quaternary level. Media Contact: Kavya Ramachandran | PR 360 |kavya@ Sethu Raj Kadaikal | PR 360 | sethuraj@
